Ignite Creation Date:
2025-12-24 @ 2:15 PM
Ignite Modification Date:
2026-02-06 @ 9:08 AM
Study NCT ID:
NCT01538095
Status:
COMPLETED
Last Update Posted:
2016-10-03
First Post:
2012-02-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02
Start Date Type:
None
Primary Completion Date:
2016-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-19
First Submit QC Date:
None
Study First Post Date:
2012-02-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-30
Last Update Post Date:
2016-10-03
Last Update Post Date Type:
ESTIMATED